Ledger.Open graph →
SEC Form D · filed March 12, 2020

Keros Therapeutics, Inc

Offering
$56.0M
Sold
$56.0M
Exemption
Rule 506(b)
Industry
Other
Location
LEXINGTON, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (19)

Carl L. Gordon · New York, NYDirectorJasbir Seehra · Lexington, MAExec · DirectorNima Farzan · San Francisco, CADirectorRan Nussbaum · Lexington, MADirectorJulius Knowles · Waltham, MADirectorKeith Regnante · Lexington, MAExecJenn Lachey · Lexington, MAExecClaudia Ordonez · Lexington, MAExecAlon Lazarus · Cambridge, MADirectorZafrira Avnur · Bozeman, MTDirectorKeith Regnante · Lexington, MAExecJenn Lachey · Lexington, MAExecClaudia Ordonez · Lexington, MAExecJasbir Seehra · Lexington, MAExec · DirectorNima Farzan · San Francisco, CADirectorAlon Lazarus · Cambridge, MADirectorRan Nussbaum · Los Angeles, CADirectorZafrira Avnur · Bozeman, MTDirectorJulius Knowles · Waltham, MADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗